Boustead Securities visits PetCure Oncology's Lakeshore (WI) Clinic to meet key team members using the Varian linear accelerator to treat tumors in pets via stereotactic radiation therapy (SRT).
Pictured above: Boustead's Brinson Lingenfelter and CEO Keith Moore with PetCure Oncology's Jenny Elliot, Radiation Therapist, Deb Fitzpatrick, Practice Director and Meredith Spence, Client Care Liaison of the Lakeshore (WI) Clinic.
PetCure Oncology's Jenny Elliot describes the protocols for using the Varian linear accelerator on pets to Boustead's Brinson Lingenfelter
PetCure Oncology's Varian linear accelerator to treat tumors in pets via stereotactic radiation therapy (SRT).
Learn more about PetCure Oncology here.
Comments